Arbutus Biopharma (ABUS) Total Liabilities: 2009-2025
Historic Total Liabilities for Arbutus Biopharma (ABUS) over the last 15 years, with Sep 2025 value amounting to $20.3 million.
- Arbutus Biopharma's Total Liabilities fell 39.46% to $20.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.3 million, marking a year-over-year decrease of 39.46%. This contributed to the annual value of $34.3 million for FY2024, which is 10.53% down from last year.
- As of Q3 2025, Arbutus Biopharma's Total Liabilities stood at $20.3 million, which was up 0.10% from $20.3 million recorded in Q2 2025.
- In the past 5 years, Arbutus Biopharma's Total Liabilities ranged from a high of $71.0 million in Q1 2022 and a low of $20.3 million during Q2 2025.
- Moreover, its 3-year median value for Total Liabilities was $37.6 million (2024), whereas its average is $35.2 million.
- In the last 5 years, Arbutus Biopharma's Total Liabilities soared by 121.35% in 2022 and then crashed by 46.02% in 2025.
- Quarterly analysis of 5 years shows Arbutus Biopharma's Total Liabilities stood at $35.0 million in 2021, then skyrocketed by 67.11% to $58.6 million in 2022, then slumped by 34.46% to $38.4 million in 2023, then decreased by 10.53% to $34.3 million in 2024, then plummeted by 39.46% to $20.3 million in 2025.
- Its last three reported values are $20.3 million in Q3 2025, $20.3 million for Q2 2025, and $37.9 million during Q1 2025.